Related references
Note: Only part of the references are listed.Extracellular loops 2 and 3 of the calcitonin receptor selectively modify agonist binding and efficacy
Emma Dal Maso et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Structure of the glucagon receptor in complex with a glucagon analogue
Haonan Zhang et al.
NATURE (2018)
Phase-plate cryo-EM structure of a biased agonist-bound human GLP-1 receptor-Gs complex
Yi-Lynn Liang et al.
NATURE (2018)
Allostery and Biased Agonism at Class B G Protein-Coupled Receptors
Denise Wootten et al.
CHEMICAL REVIEWS (2017)
A comprehensive map of molecular drug targets
Rita Santos et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Rearrangement of a polar core provides a conserved mechanism for constitutive activation of class B G protein-coupled receptors
Yanting Yin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Phase-plate cryo-EM structure of a class B GPCR-G-protein complex
Yi-Lynn Liang et al.
NATURE (2017)
Crystal structure of the GLP-1 receptor bound to a peptide agonist
Ali Jazayeri et al.
NATURE (2017)
Human GLP-1 receptor transmembrane domain structure in complex with allosteric modulators
Gaojie Song et al.
NATURE (2017)
Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein
Yan Zhang et al.
NATURE (2017)
Characterization of signal bias at the GLP-1 receptor induced by backbone modification of GLP-1
Marlies V. Hager et al.
BIOCHEMICAL PHARMACOLOGY (2017)
The peptide agonist-binding site of the glucagon-like peptide-1 (GLP-1) receptor based on site-directed mutagenesis and knowledge-based modelling
Rachel L. Dods et al.
BIOSCIENCE REPORTS (2016)
Key interactions by conserved polar amino acids located at the transmembrane helical boundaries in Class B GPCRs modulate activation, effector specificity and biased signalling in the glucagon-like peptide-1 receptor
Denise Wootten et al.
BIOCHEMICAL PHARMACOLOGY (2016)
The Extracellular Surface of the GLP-1 Receptor Is a Molecular Trigger for Biased Agonism
Denise Wootten et al.
CELL (2016)
Differential Requirement of the Extracellular Domain in Activation of Class B G Protein-coupled Receptors
Li-Hua Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
β-Arrestin-Biased Agonists of the GLP-1 Receptor from β-Amino Acid Residue Incorporation into GLP-1 Analogues
Marlies V. Hager et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
Extra-helical binding site of a glucagon receptor antagonist
Ali Jazayeri et al.
NATURE (2016)
An intrinsic agonist mechanism for activation of glucagon-like peptide-1 receptor by its extracellular domain
Yanting Yin et al.
CELL DISCOVERY (2016)
A Hydrogen-Bonded Polar Network in the Core of the Glucagon-Like Peptide-1 Receptor Is a Fulcrum for Biased Agonism: Lessons from Class B Crystal Structures
Denise Wootten et al.
MOLECULAR PHARMACOLOGY (2016)
A Pluridimensional View of Biased Agonism
Claudio M. Costa-Neto et al.
MOLECULAR PHARMACOLOGY (2016)
Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes
Chris de Graaf et al.
PHARMACOLOGICAL REVIEWS (2016)
Autocrine selection of a GLP-1R G-protein biased agonist with potent antidiabetic effects
Hongkai Zhang et al.
NATURE COMMUNICATIONS (2015)
Fulfilling the Promise of Biased G Protein-Coupled Receptor Agonism
Louis M. Luttrell et al.
MOLECULAR PHARMACOLOGY (2015)
Differential Impact of Amino Acid Substitutions on Critical Residues of the Human Glucagon-Like Peptide-1 Receptor Involved in Peptide Activity and Small-Molecule Allostery
Cassandra Koole et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
Investigating G protein signalling bias at the glucagon-like peptide-1 receptor in yeast
C. Weston et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Insights into the structure of class B GPCRs
Kaspar Hollenstein et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
Inhibitory Mechanism of an Allosteric Antibody Targeting the Glucagon Receptor
Susmith Mukund et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Structure of the human glucagon class B G-protein-coupled receptor
Fai Yiu Siu et al.
NATURE (2013)
OPINION Signalling bias in new drug discovery: detection, quantification and therapeutic impact
Terry Kenakin et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Polar transmembrane interactions drive formation of ligand-specific and signal pathway-biased family B G protein-coupled receptor conformations
Denise Wootten et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Second Extracellular Loop of Human Glucagon-like Peptide-1 Receptor (GLP-1R) Has a Critical Role in GLP-1 Peptide Binding and Receptor Activation
Cassandra Koole et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Residues within the Transmembrane Domain of the Glucagon-Like Peptide-1 Receptor Involved in Ligand Binding and Receptor Activation: Modelling the Ligand-Bound Receptor
K. Coopman et al.
MOLECULAR ENDOCRINOLOGY (2011)
Polymorphism and Ligand Dependent Changes in Human Glucagon-Like Peptide-1 Receptor (GLP-1R) Function: Allosteric Rescue of Loss of Function Mutation
Cassandra Koole et al.
MOLECULAR PHARMACOLOGY (2011)
Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 Receptor
Christina Rye Underwood et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Allosteric Ligands of the Glucagon-Like Peptide 1 Receptor (GLP-1R) Differentially Modulate Endogenous and Exogenous Peptide Responses in a Pathway-Selective Manner: Implications for Drug Screening
Cassandra Koole et al.
MOLECULAR PHARMACOLOGY (2010)
Mechanisms of peptide and nonpeptide ligand binding to class B G-protein coupled receptors
SRJ Hoare
DRUG DISCOVERY TODAY (2005)
The positive charge at Lys-288 of the glucagon-like peptide-1 (GLP-1) receptor is important for binding the N-terminus of peptide agonists
S Al-Sabah et al.
FEBS LETTERS (2003)
The glucagon-like peptide-1 receptor binding site for the N-terminus of GLP-1 requires polarity at Asp198 rather than negative charge
RL de Maturana et al.
FEBS LETTERS (2002)
Characterization of glucagon-like peptide-1 receptor-binding determinants
Q Xiao et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2000)
Share Paper
